Diagnostica Stago, Inc. recalls
7 notices naming Diagnostica Stago, Inc. as the recalling firm, since June 25, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Diagnostica Stago, Inc.: STA Staclot Protein S
Hazard (FDA): A positive drift in QC values within the reagent's stated 4-hour onboard stability period was identified
FDAMedical devices
Diagnostica Stago, Inc.: Brand Name: STA Liatest D-Di Product Name: STA Liatest D-Di Model/Catalog Number: REF…
Hazard (FDA): After receiving customer complaints, investigations confirmed the presence of a positive bias in D-Dimer measurements throughout the entire analytical range.
FDAMedical devices
Diagnostica Stago, Inc.: Brand Name: STA Liatest Free Protein S Product Name: STA Liatest Free Protein S…
Hazard (FDA): The potential of out-of-range results and an underestimation of the free protein S level in normal patient plasmas. The defect only affects normal-range values.
FDAMedical devices
Diagnostica Stago, Inc.: Asserachrom HPIA. Model/Catalog Number: 00615. The Asserachrom HPIA kit is intended for…
Hazard (FDA): Potential for defect for Asserachrom HPIA lot 271288, which can affect every well in the impacted strip and produce negative results.
FDAMedical devices
Diagnostica Stago, Inc.: Product: STA Liatest D-Di
Hazard (FDA): A potential risk of underestimation of D-Dimer (D-Di) levels with the two listed lots.
FDAMedical devices
Contamination
Diagnostica Stago, Inc.: STA Satellite. Product Code: All references. All software versions. The STA Satellite is… and 3 more
Hazard (FDA): Potential for contamination of STA-LIQUID ANTI-Xa by Stago Fibrinogen reagents in UFH and LMWH applications.
FDAMedical devices
Diagnostica Stago, Inc.: STA - Owren Koller. Model/Catalog Number: 00360 STA - Owren-Koller is a buffer solution…
Hazard (FDA): Potential for shorter clotting times in clotting tests which have a dilution, leading to possible overestimate of around 1%
FDAMedical devices